Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 11/25 05:30:00 pm
61.5150 EUR   +0.93%
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
11/19/2014 11/20/2014 11/21/2014 11/24/2014 11/25/2014 Date
61.99(c) 61.55(c) 61.556(c) 60.925(c) 60.95(c) Last
11 72 0 0 0 Volume
+2.88% -0.71% +0.01% -1.03% +0.04% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
02/25Earnings Release
Surperformance© rating of UCB SA
Trading Rating : Investor Rating :
More about the company
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 506 M
EBIT 2014 498 M
Net income 2014 247 M
Debt 2014 1 432 M
Yield 2014 1,75%
Sales 2015 3 778 M
EBIT 2015 641 M
Net income 2015 359 M
Debt 2015 1 192 M
Yield 2015 1,98%
PER 2014 47,44
PER 2015 30,22
EV / Sales 2014 3,79x
EV / Sales 2015 3,46x
Capitalization 11 865 M
More Financials
Latest news on UCB SA
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
10/22 EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
10/21UCB SA : quaterly earnings release
10/08 UCB : Georgia Bio and UCB to Host Parkinson's Gala Benefitting the National Park..
09/26 UCB : Acquisition of own shares
09/24 UCB : Patent Application Titled "Systems and Methods for Administering Medicatio..
09/23 Pending 'inversions' that new U.S. Treasury rules may hit
09/17 UCB : Patent Issued for Method for Producing Protein
09/11 Eastman Chemical to buy Taminco for $1.8 bln
09/10 UCB : Patent Application Titled "Pharmaceutical Composition Comprising Rotigotin..
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF